Raffaele De Caterina

Raffaele De Caterina's AcademicInfluence.com Rankings

Medical

#1079

World Rank

#1377

Historical Rank

Cardiology

#65

World Rank

#66

Historical Rank

medical Degrees

Raffaele De Caterina

Philosophy

#3714

World Rank

#5949

Historical Rank

Logic

#1350

World Rank

#2078

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Raffaele De Caterina Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Raffaele De Caterina's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4929)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (4221)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. (2012) (3704)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (3518)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. (2012) (3356)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (2451)
Universal definition of myocardial infarction. (2015) (2234)
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. (1995) (1824)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit (2007) (911)
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. (2004) (907)
Apixaban with antiplatelet therapy after acute coronary syndrome. (2011) (872)
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era (2020) (673)
Olive Oil and Red Wine Antioxidant Polyphenols Inhibit Endothelial Activation: Antiatherogenic Properties of Mediterranean Diet Phytochemicals (2003) (633)
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. (2016) (603)
Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420] (2011) (570)
Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses (2002) (538)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe (2010) (520)
Fatty acid modulation of endothelial activation. (2000) (501)
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. (2010) (478)
The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. (1994) (471)
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. (2004) (419)
Vitamin K antagonists in heart disease: Current status and perspectives (Section III) (2013) (385)
Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF) (2013) (385)
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. (2011) (364)
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. (2014) (326)
Recommendations for the management of patients after heart valve surgery. (2005) (320)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial (2014) (312)
Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment. (2015) (305)
Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. (2012) (284)
Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. (1997) (274)
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. (2012) (265)
Awake Systolic Blood Pressure Variability Correlates With Target-Organ Damage in Hypertensive Subjects (2007) (259)
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) (2013) (251)
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W) (2008) (235)
Stroke prevention in atrial fibrillation: Past, present and future (2017) (222)
Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. (2015) (222)
Antiplatelet agents for the treatment and prevention of atherothrombosis. (2011) (220)
n–3 Fatty Acids in Cardiovascular Disease (2011) (214)
Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2014) (205)
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation (2013) (205)
[Guidelines for cardiac pacing and cardiac resynchronization therapy]. (2008) (199)
At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products (2005) (195)
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (2012) (195)
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition (2006) (187)
Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. (2000) (187)
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. (2015) (183)
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial (2018) (181)
Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. (1998) (179)
Endothelial permeability, LDL deposition, and cardiovascular risk factors—a review (2018) (176)
General mechanisms of coagulation and targets of anticoagulants (Section I) (2013) (172)
From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammation. (2004) (172)
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2015) (166)
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis. (2014) (163)
What is 'valvular' atrial fibrillation? A reappraisal. (2014) (163)
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel (2014) (161)
Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon- (1996) (159)
Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. (2001) (158)
Stroke prevention in atrial fibrillation: Past, present and future. (2017) (157)
Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. (2009) (152)
Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes. (2011) (152)
Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. (2008) (149)
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF (2016) (149)
Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalised Nutrition: Part 1 - Fields of Precision Nutrition (2016) (147)
Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. (2004) (144)
Anticoagulants in heart disease: current status and perspectives. (2007) (143)
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. (2009) (140)
Nutritional mechanisms that influence cardiovascular disease. (2006) (138)
APPRAISE 2. Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome for the APPRAISE-2 Investigators* (2011) (136)
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study (2020) (135)
n-3 Fatty Acids in the Treatment of Diabetic Patients (2007) (134)
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable (2011) (133)
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF (PREvention oF Thromboembolic Events–European Registry in Atrial Fibrillation) (2017) (131)
Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update (2007) (131)
Digoxin and Mortality in Patients With Atrial Fibrillation. (2018) (131)
Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. (2007) (130)
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. (2004) (127)
Omega-3 Fatty Acids and the Regulation of Expression of Endothelial Pro-Atherogenic and Pro-Inflammatory Genes (2005) (127)
Failure of Thromboxane A2 Blockade to Prevent Attacks of Vasospastic Angina (1982) (124)
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease (2006) (119)
Low-Density Lipoprotein Level Reduction by the 3-Hydroxy-3-Methylglutaryl Coenzyme-A Inhibitor Simvastatin Is Accompanied by a Related Reduction of F2-Isoprostane Formation in Hypercholesterolemic Subjects: No Further Effect of Vitamin E (2002) (118)
Non-coronary atherosclerosis. (2014) (116)
Omega-3 fatty acids and endothelial leukocyte adhesion molecules. (1995) (114)
Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves. (2017) (114)
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. (2005) (112)
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. (2010) (112)
Differences among western European countries in anticoagulation management of atrial fibrillation (2014) (112)
Guidelines for the management of atrial fibrillation (Europace (2010) 12, (1360-1420)) (2011) (111)
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial (2020) (110)
Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease. (2012) (109)
Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. (1998) (108)
Distal embolization during primary angioplasty: histopathologic features and predictability. (2005) (107)
Endothelial dysfunctions: common denominators in vascular disease. (2000) (106)
Control of endothelial leukocyte adhesion molecules by fatty acids (2007) (105)
Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety. (2005) (105)
Guide for Current Nutrigenetic, Nutrigenomic, and Nutriepigenetic Approaches for Precision Nutrition Involving the Prevention and Management of Chronic Diseases Associated with Obesity (2017) (104)
Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation (2017) (103)
‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (103)
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial. (2017) (103)
Vasculoprotective potential of olive oil components. (2007) (102)
Nutraceuticals and prevention of atherosclerosis: focus on omega-3 polyunsaturated fatty acids and Mediterranean diet polyphenols. (2010) (101)
Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants (2005) (99)
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. (2006) (99)
Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches. (2017) (99)
Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition. (2014) (99)
The first 3500 years of aspirin history from its roots - A concise summary. (2019) (98)
Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials. (2010) (97)
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease. (2017) (94)
Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model (2007) (94)
Direct vascular antiatherogenic effects of oleic acid: a clue to the cardioprotective effects of the Mediterranean diet. (1999) (94)
Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase (2004) (94)
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study (2020) (93)
Statins and stroke: evidence for cholesterol-independent effects. (2002) (92)
Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. (2014) (92)
n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. (1993) (91)
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
Transplantation of Mesenchymal Cells Rejuvenated by the Overexpression of Telomerase and Myocardin Promotes Revascularization and Tissue Repair in a Murine Model of Hindlimb Ischemia (2013) (90)
n-3 Fatty acids and the inflammatory response — biological background (2001) (90)
Age‐dependent impairment of number and angiogenic potential of adipose tissue‐derived progenitor cells (2011) (89)
Simvastatin Attenuates Expression of Cytokine-inducible Nitric-oxide Synthase in Embryonic Cardiac Myoblasts* (2005) (88)
Antioxidant and Anti-Inflammatory Properties of Nigella sativa Oil in Human Pre-Adipocytes (2019) (86)
n‐3 Polyunsaturated fatty acids: update 1995 (1995) (83)
n-3 fatty acids and renal diseases. (1994) (83)
Thrombo‐embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (2012) (83)
Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis (2018) (82)
Aspects of gene polymorphisms in cardiovascular disease: the renin‐angiotensin system (2001) (81)
A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm. (1984) (81)
Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. (2009) (81)
Bleeding Time and Bleeding: An Analysis of the Relationship of the Bleeding Time Test With Parameters of Surgical Bleeding (1994) (80)
Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia (2014) (80)
Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. (2003) (79)
Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalized Nutrition: Part 2 - Ethics, Challenges and Endeavors of Precision Nutrition (2016) (78)
The dynamics of the coronary collateral circulation (2014) (78)
Quenching of Intracellular ROS Generation as a Mechanism for Oleate-Induced Reduction of Endothelial Activation and Early Atherogenesis (2002) (77)
C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. (2016) (76)
Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. (2005) (76)
Awake Blood Pressure Variability, Inflammatory Markers and Target Organ Damage in Newly Diagnosed Hypertension (2008) (76)
Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies. (2013) (75)
Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. (2006) (75)
Vasculoprotective effects of oleic acid: epidemiological background and direct vascular antiatherogenic properties. (2002) (75)
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. (2014) (74)
Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. (1993) (72)
Complete myocardial revascularization confers a larger clinical benefit when performed with state‐of‐the‐art techniques in high‐risk patients with multivessel coronary artery disease: A meta‐analysis of randomized and observational studies (2016) (72)
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure (2019) (71)
Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. (1999) (70)
High glucose-induced hyperosmolarity contributes to COX-2 expression and angiogenesis: implications for diabetic retinopathy (2016) (70)
Apixaban Compared with Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the ARISTOTLE Trial (2015) (69)
Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. (1994) (67)
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2015) (67)
Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. (2010) (67)
The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. (1993) (67)
Innate and adaptive immunity in atherosclerosis. (2018) (67)
Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. (2002) (67)
Increased serum high‐mobility group box‐1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non‐diabetic patients with heart failure (2011) (66)
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. (2006) (65)
In vitro neovasculogenic potential of resident adipose tissue precursors. (2008) (65)
Leukotriene B4 production in human atherosclerotic plaques. (1988) (64)
Adipose tissue: a new source for cardiovascular repair (2010) (64)
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. (2010) (64)
Pyrolytic Carbon Coating Enhances Teflon and Dacron Fabric Compatibility with Endothelial cell Growth (1991) (64)
Interindividual Variability in Biomarkers of Cardiometabolic Health after Consumption of Major Plant-Food Bioactive Compounds and the Determinants Involved (2017) (64)
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF. (2017) (63)
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs (2018) (61)
Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets. (2011) (61)
Nitrates and endothelial prostacyclin production: studies in vitro. (1985) (61)
Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids. (2004) (61)
Soluble E-selectin in essential hypertension: a correlate of vascular structural changes. (2001) (61)
Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48 (2016) (60)
Hepatocyte growth factor/Met gene transfer in cardiac stem cells—potential for cardiac repair (2010) (60)
Equal Antiplatelet Effects of Aspirin 50 or 324 mg/Day in Patients After Acute Myocardial Infarction (1985) (59)
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options. (2010) (58)
The left atrial appendage: from embryology to prevention of thromboembolism (2016) (58)
Endothelial dysfunctions: common denominators in vascular disease. (2000) (57)
Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. (2003) (57)
Effects of omega-3 fatty acids on cytokines and adhesion molecules (2004) (57)
Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. (2010) (56)
n-3 fatty acids in cardiovascular disease. (2011) (56)
n-3 fatty acids: Antiatherosclerotic effects (2001) (56)
Genetic determinants of blood pressure responses to caffeine drinking. (2012) (56)
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease (2016) (55)
"In vivo" imaging of atherosclerosis. (2012) (54)
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis (2020) (54)
Contemporary use of glycoprotein IIb/IIIa inhibitors (2012) (54)
Extra virgin olive oil rich in polyphenols modulates VEGF-induced angiogenic responses by preventing NADPH oxidase activity and expression. (2016) (54)
Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis (2017) (54)
Inhibition of platelet function by injectable isosorbide dinitrate. (1984) (53)
The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight—a systematic literature review (2017) (53)
PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. (2010) (52)
Corrigendum to: ‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (51)
Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction. (2015) (51)
Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients. (2011) (50)
Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction. (2011) (50)
Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial (2014) (49)
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation. (2019) (49)
Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT). (2002) (49)
Hepatocyte growth factor: Molecular biomarker and player in cardioprotection and cardiovascular regeneration (2012) (48)
Circulating endothelial progenitor cells: Do they live up to their name? (2015) (47)
Magnetocardiography: current status and perspectives. Part II: Clinical applications. (2002) (47)
Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendations. (2005) (46)
Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling (2009) (46)
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) (2019) (45)
The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation (2019) (45)
Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. (2003) (45)
Additive Regulation of Adiponectin Expression by the Mediterranean Diet Olive Oil Components Oleic Acid and Hydroxytyrosol in Human Adipocytes (2015) (45)
Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial (2017) (45)
Relevance of new drug discovery to reduce NF-κB activation in cardiovascular disease. (2012) (44)
Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease (2019) (44)
Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function. (1985) (44)
The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia (2008) (44)
The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. (2013) (43)
Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. (2011) (43)
Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes. (2016) (43)
Prevalence of anticardiolipin antibodies in coronary artery disease. (1990) (43)
Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects. (1992) (42)
Trimetazidine improves post-ischemic recovery by preserving endothelial nitric oxide synthase expression in isolated working rat hearts. (2007) (42)
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage. (2018) (42)
Pathophysiology of ischemia-reperfusion injury: experimental data. (2002) (42)
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors (2017) (42)
Benefit/Risk Profile of Combined Antiplatelet Therapy with Ticlopidine and Aspirin (1991) (41)
Up-titration of allopurinol in patients with gout. (2014) (41)
Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials (2016) (41)
The epicardial adipose tissue and the coronary arteries: dangerous liaisons (2019) (41)
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W. (2010) (40)
Inhibition of endothelial cell activation by nitric oxide donors. (2000) (40)
Age-dependence of risk factors for carotid stenosis: an observational study among candidates for coronary arteriography. (2001) (40)
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials. (2015) (40)
Circulating levels of Nɛ-(carboxymethyl)lysine are increased in systemic sclerosis (2007) (40)
Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction (2008) (40)
Optical coherence tomography accurately identifies intermediate atherosclerotic lesions--an in vivo evaluation in the rabbit carotid artery. (2007) (40)
Magnetocardiography: current status and perspectives. Part I: Physical principles and instrumentation. (2002) (39)
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) (2021) (39)
Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients (2013) (38)
Omega–3 Fatty Acids, Inflammation and Angiogenesis: Nutrigenomic Effects as an Explanation for Anti-Atherogenic and Anti-Inflammatory Effects of Fish and Fish Oils (2007) (38)
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies (2020) (38)
Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells. (2008) (37)
Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial. (2015) (37)
Antihypertensive and Metabolic Effects of Telmisartan in Hypertensive HIV-Positive Patients (2011) (37)
The Prominent Role of P38 Mitogen-Activated Protein Kinase in Insulin-Mediated Enhancement of VCAM-1 Expression in Endothelial Cells (2007) (36)
Inhaled nitric oxide: more than a selective pulmonary vasodilator (2002) (36)
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study. (2018) (36)
Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects. (2007) (36)
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes (2012) (35)
Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factor-kappaB through antioxidant effects. (2002) (34)
Endothelial dysfunctions and vascular disease (2007) (34)
Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension (2017) (34)
n-3 Fatty Acids in the Treatment of Diabetic Patients Biological rationale and clinical data (2007) (34)
Hydroxytyrosol Modulates Adipocyte Gene and miRNA Expression Under Inflammatory Condition (2019) (34)
High glucose-induced hyperosmolarity impacts proliferation, cytoskeleton remodeling and migration of human induced pluripotent stem cells via aquaporin-1. (2014) (33)
PCSK9 and atherosclerosis: Looking beyond LDL regulation (2020) (33)
Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction. (1985) (33)
Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina (2019) (33)
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study (2019) (32)
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe (2014) (32)
Endothelial dysfunctions: common denominators in vascular disease (2000) (32)
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. (2004) (32)
Effect of Chronic Hypoxia on Inducible Nitric Oxide Synthase Expression in Rat Myocardial Tissue (2003) (32)
Organic Nitrates: Direct Antiplatelet Effects and Synergism with Prostacyclin (1988) (31)
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy. (2018) (31)
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. (2016) (31)
Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry. (2016) (31)
Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. (2001) (30)
Recent developments in cardiovascular stem cells. (2014) (30)
Antiplatelet effects of verapamil in man (1981) (30)
Heart failure due to right ventricular apical pacing: the importance of flow patterns. (2016) (30)
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD). (2012) (29)
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. (2007) (29)
The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. (2021) (29)
111In Platelet Scintigraphy for the Noninvasive Detection of Carotid Plaque Thrombosis (2001) (28)
Complete myocardial revascularization: between myth and reality (2005) (28)
Stem cells and growth factor delivery systems for cardiovascular disease. (2011) (28)
Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease. (2015) (28)
Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves: Is the Door Still Open? (2018) (27)
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score. (2019) (27)
Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial. (2020) (27)
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations (2018) (26)
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion (2017) (26)
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial (2015) (26)
Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease. (2012) (26)
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy. (2018) (26)
VEGF receptor switching in heart development and disease. (2009) (26)
Mid-term outcomes after percutaneous interventions in coronary bifurcations. (2019) (25)
Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial. (2021) (25)
Ranolazine in the prevention of anthracycline cardiotoxicity. (2014) (25)
Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. (1985) (25)
Effects of Olive Oil on Blood Pressure: Epidemiological, Clinical, and Mechanistic Evidence (2020) (25)
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe) (2019) (24)
The inhibition of endothelial activation by unsaturated fatty acids (2007) (24)
Endothelial Functions and Dysfunctions (2007) (24)
Involvement of the TP receptor in TNF-α-induced endothelial tissue factor expression. (2014) (24)
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy. (2017) (24)
Pharmacological modulation of vascular inflammation in atherothrombosis (2010) (24)
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study). (2016) (24)
Co-Activation of Nuclear Factor-κB and Myocardin/Serum Response Factor Conveys the Hypertrophy Signal of High Insulin Levels in Cardiac Myoblasts* (2014) (24)
Complete myocardial revascularization: between myth and reality. (2005) (24)
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. (2018) (24)
Chronic Ischaemic Heart Disease (2009) (24)
NA+/H+ Exchanger 1-and Aquaporin-1-Dependent Hyperosmolarity Changes Decrease Nitric Oxide Production and Induce VCAM-1 Expression in Endothelial Cells Exposed to High Glucose (2010) (24)
ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis. (2016) (23)
Inhibition of Major Histocompatibility Complex Class II Gene Transcription by Nitric Oxide and Antioxidants* (2002) (23)
Isolated troponin increase after percutaneous coronary interventions: does it have prognostic relevance? (2012) (23)
Intraoperative ischemia and long-term events after minimally invasive coronary surgery. (2004) (23)
EMERALD, AIMI, and PROMISE: is there still a potential for embolic protection in primary PCI? (2006) (23)
Parallel decrease of tissue factor surface exposure and increase of tissue factor microparticle release by the n-3 fatty acid docosahexaenoate in endothelial cells (2007) (22)
[Advanced glycation endproducts: implications for accelerated atherosclerosis in diabetes]. (2004) (22)
Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single-vessel coronary artery disease. (1999) (22)
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study (2018) (22)
Fatty Acids in Cardiovascular Disease (2011) (21)
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies. (2019) (21)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial (2016) (21)
Vasomotor effects of iodinated contrast media: just side effects? (2003) (21)
Prominent role of NF-kappaB in the induction of endothelial activation by endogenous nitric oxide inhibition. (2009) (21)
The C242T polymorphism of the p22phox component of NAD (P)H oxidase and vascular risk (2008) (21)
Induction of Endothelial-Leukocyte Interaction by Interferon-γ Requires Coactivation of Nuclear Factor-κB (2001) (21)
Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe (2018) (21)
Non-invasive in vivo detection of peripheral limb ischemia improvement in the rat after adipose tissue-derived stromal cell transplantation. (2012) (21)
Low-Dose Aspirin and Upper Gastrointestinal Bleeding in Primary Versus Secondary Cardiovascular Prevention: A Population-Based, Nested Case–Control Study (2014) (21)
Role and importance of ultrasound lung comets in acute cardiac care (2015) (21)
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study (2019) (21)
Blood - Artificial Surface Interactions during Cardiopulmonary Bypass (1990) (21)
Modulation of Arachidonic Acid Metabolism in Human Endothelial Cells by Glucocorticoids (1986) (21)
MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia. (2001) (21)
The new oral anticoagulants in atrial fibrillation: once daily or twice daily? (2013) (21)
Plasma N-ϵ-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting (2008) (20)
Release of Contracting Autacoids by Aortae of Normal and Atherosclerotic Rabbits (1992) (20)
Prognostic Role of Cardiac Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy. (2018) (20)
A fast and effective method to assess myocardial hyperemia in acute myocarditis by magnetic resonance (2014) (20)
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation (2019) (20)
Early Subclinical Atherosclerosis in Gestational Diabetes: The Predictive Role of Routine Biomarkers and Nutrigenetic Variants (2018) (20)
Coronary Artery Anomalies (2021) (20)
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery. (2007) (20)
Aspirin overprescription in primary cardiovascular prevention. (2006) (20)
Stroke prevention in atrial fibrillation: current status and near-future directions. (2011) (20)
Oxidative stress and vascular stiffness in hypertension: A renewed interest for antioxidant therapies? (2019) (19)
Nutrients and gene expression. (2004) (19)
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study (2019) (19)
Cholesterol-lowering interventions and stroke: Insights from IMPROVE-IT. (2016) (19)
Coronary vasodilation by nitrates is not mediated by the prostaglandin system: a quantitative cineangiographic study. (1986) (19)
Glucose Metabolism, Hyperosmotic Stress, and Reprogramming of Somatic Cells (2013) (19)
Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis. (2017) (19)
Inconsistency of different methods for assessing ex vivo platelet function: relevance for the detection of aspirin resistance (2010) (19)
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study (2020) (19)
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. (2016) (19)
Coronary arteriovenous fistula presenting as chronic pericardial effusion. (2006) (19)
Omega-3 fatty acids, atherogenesis, and endothelial activation (2007) (19)
Cellular effects of thrombin: pharmacology of the receptor(s) in various cell types and possible development of receptor antagonists. (1993) (19)
Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis (2019) (19)
Pathways and Drugs in Pulmonary Arterial Hypertension – Focus on the Role of Endothelin Receptor Antagonists (2015) (18)
Nitrates and Other Nitric Oxide Donors in Cardiology - Current Positioning and Perspectives (2012) (18)
High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis (2009) (18)
Hospital admissions for orthostatic hypotension and syncope in later life: insights from the Malmö Preventive Project (2017) (18)
Urinary albumin excretion and atherosclerosis in essential hypertension. (1997) (18)
Clopidogrel "resistance": pre- vs post-receptor determinants. (2013) (18)
Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha. (2009) (18)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial. (2016) (18)
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly. (2018) (17)
Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF. (2017) (17)
Bivalirudin for acute coronary syndromes: premises, promises and doubts (2014) (17)
Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes (2012) (17)
Causal relationship between influenza infection and risk of acute myocardial infarction: pathophysiological hypothesis and clinical implications (2020) (17)
COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. (2021) (17)
Moving towards Specific Nutrigenetic Recommendation Algorithms: Caffeine, Genetic Variation and Cardiovascular Risk (2016) (17)
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial (2019) (17)
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation (2018) (17)
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants (2016) (17)
Fish oil and ischaemic heart disease. (1993) (17)
Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: relationship between plasma drug concentration and hemodynamic effects. (1990) (16)
Grading of aortic stenosis severity: a head-to-head comparison between cardiac magnetic resonance imaging and echocardiography (2018) (16)
Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents (2012) (16)
Facilitated PCI: Rationale, Current Evidence, Open Questions, and Future Directions (2008) (16)
Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells. (2013) (16)
Mechanisms for the in vivo antiplatelet effects of isosorbide dinitrate. (1988) (16)
Sudden cardiac death in an Italian competitive athlete: Pre-participation screening and cardiovascular emergency care are both essential. (2016) (16)
Transplantation of Mesenchymal Cells Improves Peripheral Limb Ischemia in Diabetic Rats (2014) (16)
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation. (2016) (16)
Imaging of the vulnerable carotid plaque (2020) (16)
[Expert consensus document on the use of antiplatelet agents]. (2004) (16)
Atherogenesis and Diabetes, Focus on Insulin Resistance and Hyperinsulinemia (2012) (16)
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study (2021) (16)
Proton pump inhibitors and clopidogrel: an association to avoid? (2014) (16)
Sodium-hydrogen exchangers (NHE) in human cardiovascular diseases: interfering strategies and their therapeutic applications. (2013) (15)
Defective recovery of QT dispersion predicts late cardiac mortality after percutaneous coronary intervention (2011) (15)
Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes (2020) (15)
Localizing factors in atherosclerosis (2015) (15)
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease (2021) (15)
The d-Enantiomer Form of Indobufen Totally Accounts for the Anti-Cyclooxygenase and Antiplatelet Activity Ex Vivo and for the Increase in Bleeding Time by Indobufen in Man (1992) (15)
Effects of atrial natriuretic factor on human platelet function. (1985) (15)
n-3 fatty acids and vascular disease : background and pathophysiology - hyperlipidaemia - renal diseases - ischaemic heart disease (1993) (14)
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta‐analysis (2018) (14)
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men. (2007) (14)
Right heart‐pulmonary circulation unit and cardiac resynchronization therapy (2017) (14)
Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4. (1988) (14)
Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin. (2019) (14)
Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications (2006) (13)
The current role of anticoagulants in cardiovascular medicine (2009) (13)
Thromboxane-B2 generation during ex-vivo platelet aggregation. (1984) (13)
Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes (2018) (13)
From short‐term blood pressure variability to atherosclerosis: Relative roles of vascular stiffness and endothelial dysfunction (2020) (13)
Impaired fasting plasma glucose and long-term cardiovascular risk: still a foggy relationship. (2010) (13)
Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications (2021) (13)
Concentric Remodeling Detection by Magnetocardiography in Patients with Recent Onset Arterial Hypertension (2004) (13)
Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury (2016) (13)
Tumor necrosis factor-alpha and cardiovascular diseases. (2001) (13)
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina (2021) (13)
Nutrients and gene expression. (2001) (13)
Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study. (2016) (12)
Cholesterol lowering and stroke: no longer room for pleiotropic effects of statins - confirmation from PCSK9 inhibitor studies. (2019) (12)
Association of the European Society of Cardiology echocardiographic probability grading for pulmonary hypertension with short and mid-term clinical outcomes after heart valve surgery. (2020) (12)
Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part I: The use of ROC curves in diagnostic medicine and electrocardiographic markers of ischaemia (2007) (12)
Three-Dimensional Echographic Evaluation of Carotid Artery Disease (2018) (12)
Sulfido‐peptide leukotrienes in coronary heart disease – relationship with disease instability and myocardial ischaemia (2010) (12)
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin. (2018) (12)
OUTCOMES IN 2824 PATIENTS WITH VALVULAR HEART DISEASE TREATED WITH EDOXABAN OR WARFARIN IN THE ENGAGE AF-TIMI 48 TRIAL (2016) (12)
Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation (2020) (12)
Cytochromes CYP1A1 and CYP1B1: new pieces in the puzzle to understand the biomechanical paradigm of atherosclerosis. (2008) (12)
Cell based mechanosensing in vascular patho-biology: More than a simple go-with the flow. (2018) (12)
Distribution function of transit times in the human pulmonary circulation. (1994) (12)
A Cost-effectiveness Analysis of Aspirin versus Oral Anticoagulants after Acute Myocardial Infarction in Italy (1998) (12)
Aquaporin-1 and sodium-hydrogen exchangers as pharmacological targets in diabetic atherosclerosis. (2015) (11)
The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease—The REMEDY-EPC early substudy (2017) (11)
Mediterranean Diet Polyphenols (2015) (11)
The direct effects of metformin on platelet function in vitro (2004) (11)
Inflammation in early atherogenesis: impact of ACE inhibition (2003) (11)
Epigenetic regulation of insulin-like growth factor signaling: A novel insight into the pathophysiology of neonatal pulmonary hypertension. (2015) (11)
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination (2004) (11)
2016 ESC guidelines for the diagnosis and treatment of atrial fibrillation developed in collaboration with the EACTS (2017) (11)
Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects (1999) (11)
Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study. (2017) (11)
State of play and future direction with NOACs: An expert consensus. (2018) (11)
Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. (2001) (11)
Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection. (2013) (11)
Bedside monitoring of antiplatelet therapy for coronary stenting. (2013) (11)
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway (2020) (11)
Transcriptome-based identification of new anti-anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions (2015) (11)
The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design (2019) (10)
Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part II: The use of ROC curves in the choice of electrocardiographic stress test markers of ischaemia (2008) (10)
Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups. (1998) (10)
New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism. (2004) (10)
Differential Ability of Human Endothelial Cells to Internalize and Express Exogenous DNA (2004) (10)
Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status. (2019) (10)
MR Angiography, MR Imaging and Proton MR Spectroscopy In-Vivo Assessment of Skeletal Muscle Ischemia in Diabetic Rats (2012) (10)
Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man. (1993) (10)
Fish Oil and Vascular Disease (1992) (10)
Management of atrial fibrillation in the Emergency Department: current approach and future expectations. (2013) (10)
EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO AGE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION (2013) (10)
Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship (2014) (10)
Omega-3 fatty acid supplementation and lipoprotein(a) concentrations in patients with chronic glomerular diseases. (1996) (10)
Isolated creatine kinase-MB rise with normal cardiac troponins: a strange occurrence with difficult interpretation (2011) (9)
In vivo actions of organic nitrates on platelet function in humans. (1989) (9)
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism. (2020) (9)
Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. (2006) (9)
Clinical use of aspirin in ischemic heart disease: past, present and future. (2012) (9)
Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients. (2014) (9)
Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy. (2020) (9)
Factor XI inhibitors: cardiovascular perspectives. (2022) (9)
Towards a molecular understanding of the atheroprotective effects of estrogens: a review of estrogen effects on endothelial activation. (2000) (9)
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (2022) (9)
Aspirin and the prevention of a common disease: Colorectal cancer. (2017) (9)
Methodological assessment and applications of a radioimmunoassay for thromboxane (TxB2) to measurement of TxB2 release by platelets. (1982) (9)
Functional endothelial damage by high-potassium cardioplegic solutions to saphenous vein bypass grafts. (1985) (9)
Imaging of the Vulnerable Carotid Plaque (2021) (9)
Understanding the complexity of abciximab-related thrombocytopenia (2010) (9)
The WOEST study: Critical considerations and applicability (2014) (9)
Increased left atrial size in obese children and its association with insulin resistance: a pilot study (2015) (9)
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies. (2020) (9)
Effects of diet and of dietary components on endothelial leukocyte adhesion molecules (1999) (9)
Modulation of cell activation by n-3 fatty acids. (1993) (9)
Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification (2019) (8)
Drug-eluting balloons for percutaneous coronary interventions (2008) (8)
drug therapy n – 3 Fatty Acids in Cardiovascular Disease (2011) (8)
Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk (2017) (8)
Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors. (2008) (8)
Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide (2017) (8)
Targeting thrombin long-term after an acute coronary syndrome: Opportunities and challenges. (2016) (8)
A comparison of the diagnostic performance of the ST/HR hysteresis with cardiopulmonary stress testing parameters in detecting exercise-induced myocardial ischemia. (2013) (8)
Pre‐treatment high‐sensitivity troponin T for the short‐term prediction of cardiac outcomes in patients on immune checkpoint inhibitors (2020) (8)
Mechanisms of nitrate tolerance: potential roles of folate (2003) (8)
Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair. (2020) (8)
Early restenosis after drug-eluting stent implantation: A putative role for platelet activation. (2007) (8)
New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications (2016) (8)
Antithrombotic Management in Patients with Prosthetic Valves (2012) (8)
Determinants of subacute response to clopidogrel: relative impact of CYP2C19 genotype and PGE1/adenylate cyclase signalling. (2015) (8)
Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model (2021) (8)
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different mates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries. (2021) (8)
A Prostacyclin-sparing Effect of Indobufen vs. Aspirin (1996) (7)
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis. (2022) (7)
Inhibition of eicosanoid formation and lipocortin induction by glucocorticoids in human cell lines and in patients with inflammatory lung disease. (1992) (7)
Analysis of stent edge restenosis with different forms of brachytherapy. (2002) (7)
Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease. (2019) (7)
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. (2014) (7)
Effects of the direct thrombin inhibitor dabigatran etexilate vs warfarin on platelet function in patients with atrial fibrillation (2013) (7)
Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program (2021) (7)
Coffee: Health Effects (2016) (7)
Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis. (2014) (7)
New anticoagulants for atrial fibrillation (2009) (7)
An overview of n-3 fatty acids in clinical renal diseases. (1993) (7)
Atherogenesis and diabetes: focus on insulin resistance and hyperinsulinemia. (2012) (7)
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy (2016) (7)
Impact of antiplatelet therapy in heart disease. (2012) (7)
Nutrigenomic Effect of Hydroxytyrosol in Vascular Endothelial Cells: A Transcriptomic Profile Analysis (2021) (7)
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors. (2010) (7)
Coronary vasodilation by nitrates is not mediated by the prostaglandin system: an angiographic and hemodynamic study. (1983) (7)
Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease? (2017) (7)
Studies on the induction of lipocortin-1 by glucocorticoids. (1993) (7)
Isolated Exercise-Induced Pulmonary Hypertension Associates with Higher Cardiovascular Risk in Scleroderma Patients (2020) (7)
Dose- and time-related vasodilator response of conduit coronary arteries to intracoronary isosorbide dinitrate in human beings. (1989) (6)
[Hyperhomocysteinemia and vascular disease]. (1996) (6)
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas (2021) (6)
Aspirin Therapy for Primary Prevention: The Case for Continuing Prescribing to Patients at High Cardiovascular Risk—A Review (2019) (6)
The usefulness of the anaerobic threshold in the assessment and prognostic evaluation of the patient with dyspnea. (2012) (6)
Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem (2020) (6)
Lung ultrasonography: a practical guide for cardiologists (2017) (6)
Patient management and care after primary percutaneous coronary intervention: reinforcing a continuum of care after primary percutaneous coronary intervention. (2010) (6)
Reduction of atherothrombotic burden before stent deployment in non‐ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose‐dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study (2016) (6)
Verapamil Reduces Coronary Endothelium Damage and Cardiomyocyte Necrosis but not Apoptosis after Ischemia and Reperfusion: Ex Vivo Study in Rat Hearts (2002) (6)
Uric acid levels and platelet function in humans. An in-vivo ex-vivo study. (1983) (6)
'Missing' coronary arteries at urgent coronary angiography for ST-elevation myocardial infarction. (2010) (6)
The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease. (2020) (6)
Antiatherogenic effects of n-3 fatty acids - evidence and mechanisms (2006) (6)
Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence. (2020) (6)
Opportunities and Challenges in Nutrigenetics/Nutrigenomics and Health (2010) (6)
Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty (2020) (6)
The current role of anticoagulants in cardiovascular medicine (2009) (6)
Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial (2016) (6)
Telomerase/myocardin expressing mesenchymal cells induce survival and cardiovascular markers in cardiac stromal cells undergoing ischaemia/reperfusion (2021) (6)
Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy? (2020) (6)
Long-Term Engraftment and Angiogenic Properties of Lentivirally Transduced Adipose Tissue-Derived Stromal Cells (2013) (6)
Impaired adenylate cyclase signaling in acute myocardial ischemia: Impact on effectiveness of P2Y12 receptor antagonists. (2019) (6)
[n-3 fatty acids and cardiovascular diseases: update to 1996]. (1996) (5)
Glycoprotein IIb-IIIa Antagonists in Non-ST Elevation Acute Coronary Syndromes and Percutaneous Interventions: from Pharmacology to Individual Patient's Therapy: Part 1: The Evidence of Benefit (2004) (5)
Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs. (2020) (5)
Low-Density Lipoprotein Level Reduction by the 3-Hydroxy-3-Methylglutaryl Coenzyme-A Inhibitor Simvastatin Is Accompanied by a Related Reduction of F2-Isoprostane Formation in Hypercholesterolemic Subjects (2002) (5)
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. (2020) (5)
A case report of multisite arterial thrombosis in a patient with coronavirus disease 2019 (COVID-19) (2020) (5)
Platelet radiolabelling with 111 Indium for in vivo studies: a methodological reappraisal. (1995) (5)
Role of nutrients and physical activity in gene expression. (2005) (5)
Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina. (1990) (5)
Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillation. (2020) (5)
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review (2017) (5)
Von Willebrand factor, ADAMTS13, and coronary microvascular obstruction: beautiful hypotheses, ugly facts. (2016) (5)
[Prevention in coronary postangioplasty restenosis with omega-3 fatty acids. Results of the Italian study on prevention of restenosis with esapent (ESPRIT)]. (1999) (5)
Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility. (2021) (5)
ADMA and SDMA predict outcomes in patients with chronic atrial fibrillation: an ARISTOTLE substudy (2013) (5)
Anti‐atherogenic Effects of Omega‐3 Fatty Acids (2007) (5)
Working Group on Peripheral Circulation (2014) (5)
Antiplatelet effects of isosorbide dinitrate in man. (1983) (5)
The double bond in unsaturated fatty acids is the necessary and sufficient requirement for the inhibition of expression of endothelial leukocyte adhesion molecules through interference with nuclear factor-κB activation (2007) (5)
Biventricular Takotsubo syndrome in a patient with coronary abnormality and end-stage renal disease (2013) (5)
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). (2018) (5)
Hydroxytyrosol, a phenolic antioxidant from olive and olive oil, reduces metalloproteinase(MMP)-9 expression and activity in human monocytoid cells - possible contribution to plaque stability (2006) (5)
Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemia. (2015) (5)
Activity of resveratrol on endothelial adhesion molecules (1997) (5)
[Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms]. (1996) (5)
[Guidelines in cardiac pacing and resynchronization therapy]. (2007) (5)
[Contrast-induced acute kidney injury in cardiology]. (2016) (5)
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment (2015) (5)
The regulation of expression of endothelial leukocyte adhesion molecules as a regulatory step in atherosclerosis and inflammation (1996) (5)
CorrigendumCorrigendum to “Stem cells and growth factor delivery systems for cardiovascular disease” [J. Biotechnol. 154 (2011) 291–297] (2011) (5)
Comprar Achieving Cultural Competency: A Case-Based Approach to Training Health Professionals | Raffaele De Caterina | 9781405180726 | Wiley (2009) (5)
Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence. (2021) (5)
Erratum: The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition (Proceedings of the National Academy of Sciences of the United States of America (2006) 103, 41, (15184-15189) DOI: 10.1073-pnas.0510086103) (2007) (5)
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry (2020) (5)
Iloprost in Prinzmetal's angina. (1986) (4)
Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation (2021) (4)
[The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice]. (2001) (4)
The co‐predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation (2019) (4)
Magnetic resonance spectroscopy to detect functional improvement by adipose tissue-derived stromal cell transplantation in the ischemic hind limb in diabetic rats (2013) (4)
Epidemiology of olive oil and cardiovascular disease. (2006) (4)
RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial. (2022) (4)
Co‐expression of glycosylated aquaporin‐1 and transcription factor NFAT5 contributes to aortic stiffness in diabetic and atherosclerosis‐prone mice (2020) (4)
Does high on-treatment platelet aggregability reflect poor individual response to clopidogrel? (2020) (4)
Fraud in biomedical research - the role of journal Editors. (2011) (4)
Endothelial Activation and the Initiation of Atherosclerosis (2007) (4)
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial (2020) (4)
Aspirin for primary cardiovascular prevention: is there a need for risk stratification? (2019) (4)
Comparative law and economics (2012) (4)
Iatrogenic coronary-right ventricular fistula complicated by coronary thrombosis (2014) (4)
Principles of Nutrigenetics and Nutrigenomics (2020) (4)
Fraud in biomedical research--the role of journal editors. (2011) (4)
Fatty acid modulation of endothelial activation 1 – 3 (1999) (4)
The value of imaging in subclinical coronary artery disease. (2016) (4)
ESC position paper Anticoagulants in heart disease : current status and perspectives ‡ (2007) (4)
[Practice guidelines 2007 for the treatment of arterial hypertension]. (2007) (4)
Alcohol and atherosclerosis: a double edged sword. (2012) (4)
Towards an understanding of the molecular pathogenesis of acute coronary syndromes. (1997) (4)
SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY (2007) (4)
Characterization and Potential for Cardiovascular Repair (2009) (4)
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
Left ventricular size predicts clinical benefit after percutaneous mitral valve repair for secondary mitral regurgitation: A systematic review and meta-regression analysis. (2019) (4)
Measurements of thromboxane production and their clinical significance in coronary heart disease (2012) (4)
[Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry]. (2014) (4)
Opportunities and Challenges in Nutrigenetics/Nutrigenomics and Health (2011) (4)
The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study (2021) (4)
The long-term use of blockers of the platelet ADP receptor in acute coronary syndromes. (2001) (3)
Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks. (2003) (3)
Aspirin in heart failure: don't throw the baby (aspirin) out with the bathwater (2017) (3)
Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry (2021) (3)
Inhibiting thrombosis without causing bleeding: can EP3 blockers fulfil the dream? (2014) (3)
[QT dispersion and myonecrosis after stent percutaneous coronary intervention]. (2004) (3)
Where are clots in atrial fibrillation? Did we have the wrong assumptions over the last decades? (2020) (3)
Intracoronary vs intravenous abciximab in interventional cardiology: A reopened question? (2015) (3)
Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis (2022) (3)
Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF Program (2021) (3)
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. (2019) (3)
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation. (2018) (3)
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: A systematic review and meta-analysis. (2021) (3)
Percutaneous interventions on arterial conduits. (2001) (3)
Exercise-induced pulmonary hypertension in HIV patients: Association with poorer clinical and immunological status. (2021) (3)
Risk of stroke after transcatheter aortic valve implant: the role of the new oral anticoagulants (2019) (3)
New insights from the MESA study: increased high-sensitivity troponins as a cardiovascular risk factor (2021) (3)
PrevenTion of contrast-inducEd nephropAThy with urinE alkalinization: the TEATE study design. (2019) (3)
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering (2021) (3)
Intraventricular flow patterns during right ventricular apical pacing (2019) (3)
[Management of thromboembolic risk in patients with atrial fibrillation in Italy: follow-up data from the PREFER in AF European Registry]. (2016) (3)
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis (2021) (3)
Analysis of the Anti-Inflammatory and Anti-Osteoarthritic Potential of Flonat Fast®, a Combination of Harpagophytum Procumbens DC. ex Meisn., Boswellia Serrata Roxb., Curcuma longa L., Bromelain and Escin (Aesculus hippocastanum), Evaluated in In Vitro Models of Inflammation Relevant to Osteoarthrit (2022) (3)
Sex‐related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model (2022) (3)
Effect of nabumetone on metabolism of renal arachidonate in humans. (1992) (3)
Aerobic exercise-related attenuation of arterial pulmonary hypertension: A right arrow targets the disease? (2016) (3)
Coronary artery remodelling in atherosclerosis: unfortunately unpredictable. (2006) (3)
Left Atrial Remodeling and Stroke in Patients With Sinus Rhythm and Normal Ejection Fraction: ARIC‐NCS (2022) (3)
Working Group on Thrombosis (2005) (3)
The Changing Landscape in Oral Anticoagulation – The Last Pieces of the Puzzle (2013) (3)
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers. (2015) (3)
[Soluble-phase adhesion molecules as biohumoral markers of vascular activation in vivo]. (1999) (3)
Treatment Satisfaction in Patients with Atrial Fibrillation on New Oral Anticoagulants as Measured with Pact-Q2: Prefer in AF Registry (2013) (3)
Polymorphisms related to inflammation in the interleukin-1 system genes: a step forward in the search for predisposing conditions to ischemic heart disease. (1999) (3)
Nutrients and Gene Expression in Cardiovascular Disease (2020) (3)
Docosahexaenoic acid ethyl esters ineffective? (2013) (3)
Epidemiology of n-3 fatty acids and disease. (1993) (3)
Cancer after intense and prolonged antiplatelet therapies--fact or fiction? (2015) (3)
Anti-D treatment for chronic immune thrombocytopenic purpura: clinical and laboratory aspects. (1998) (3)
Endothelial progenitor cells in coronary atherosclerosis and percutaneous coronary intervention: A systematic review and meta-analysis. (2022) (3)
Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible? (2021) (3)
Abstract 16800: Anemia Predicts Bleeding and Mortality, but Not Stroke, in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (2014) (3)
Aspirin for primary cardiovascular prevention: why the wonder drug should not be precipitously dismissed. (2020) (3)
Advanced Glycation Endproducts and the Accelerated Atherosclerosis in Diabetes (2007) (3)
European Summer School on Nutrigenomics. September 1–5, 2014 Camerino, Italy: Abstracts (2014) (3)
Mechanisms of Plaque Progression and Complications (2007) (3)
Glycoprotein IIb-IIIa Antagonists in Non-ST Elevation Acute Coronary Syndromes and Percutaneous Interventions: From Pharmacology to Individual Patient’s Therapy: Part 2: When and How to Use Various Agents (2004) (3)
Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials (2020) (3)
Abstract 17216: Aquaporin-1 is Required for Vascular Differentiation of Human Induced Pluripotent Stem Cells Following Exposure to Glucose-Induced Hyperosmolarity (2011) (3)
Changes in Plasma Lipid and Lipoprotein Levels in Men and Women After a Program of Moderate Exercise (2005) (3)
Glycoprotein IIb-IIIa inhibitors in unstable coronary syndromes and percutaneous interventions--a conservative approach. (2003) (3)
Predictors of strut coverage of drug eluting stent implantation in diabetic patients. (2019) (3)
Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” (2021) (2)
Leukotriene production by human vascular tissues: possible link between the nature of the atherosclerotic lesions and their clinical activity (1989) (2)
[Products of advanced glycosylation and the pathogenesis of accelerated atherosclerosis in diabetes]. (1996) (2)
Marine n-3 Fatty Acids and Vascular Disease: Solid Evidence in a Sea of Uncertainties. (2018) (2)
Coffee Bioactive N-Methylpyridinium Attenuates Tumor Necrosis Factor (TNF)-α-Mediated Insulin Resistance and Inflammation in Human Adipocytes (2021) (2)
Comprar Endothelial Dysfunctions in Vascular Disease | Raffaele De Caterina | 9781405122085 | Blackwell Publishing (2007) (2)
All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT (2016) (2)
Low-Thrombogenicity Mechanical Heart Valves: Which Antithrombotic Strategy? (2018) (2)
How safe are non-vitamin K antagonist oral anticoagulants in atrial fibrillation? (2016) (2)
Influence of device selection on angiographic outcomes for the treatment of in-stent restenosis. A sub analysis from the Washington Radiation for In-Stent restenosis Trial (WRIST). (2002) (2)
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". (2014) (2)
Aspirin in heart failure: don't throw the baby (aspirin) out with the bathwater (2017) (2)
Polymorphisms related to inflammation in the interleukin-1 system genes: a step forward in the search for predisposing conditions to ischemic heart disease. (1999) (2)
Genetic and nutritional interactions in cardiovascular disease. (2011) (2)
Quantification of atherosclerotic plaques in carotid arteries by three ‐ dimensional ultrasound Year (2)
POORLY CONTROLLED BLOOD PRESSURE IS INDEPENDENTLY ASSOCIATED WITH A 50% HIGHER RISK OF STROKE OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL (2014) (2)
Actinomycin D-eluting stents do not reduce the risk of restenosis. Commentary. (2005) (2)
Images in cardiovascular medicine. Membrane-type subaortic stenosis in the adult. (2003) (2)
[Hemolysis following valve surgery]. (2003) (2)
[Myocardial infarction with normal coronary arteries: a condition with multiple etiology and variable prognosis]. (2006) (2)
Cancer after intense and prolonged antiplatelet therapies – fact or fiction? (2015) (2)
[Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment]. (2019) (2)
Characteristics of thromboxane production by the isolated-perfused rat heart. (1987) (2)
Antithrombotic treatment strategies after PCI (2020) (2)
BENEFIT OF ATORVASTATIN RELOAD ON ENDOTHELIAL PROGENITOR CELLS IN PATIENTS ON CHRONIC STATIN TREATMENT UNDERGOING PCI (2013) (2)
Transcriptional regulation of vascular smooth muscle cell proliferation, differentiation and senescence: Novel targets for therapy. (2022) (2)
Clinical Performance of Oral Anticoagulants in Elderly with Atrial Fibrillation and Low Body Weight: Insight into Italian Cohort of PREFER-AF and PREFER-AF Prolongation Registries (2022) (2)
Correction: Transcriptome-Based Identification of New Anti-Anti-Inflammatory and Vasodilating Properties of the n-3 Fatty Acid Docosahexaenoic Acid in Vascular Endothelial Cell Under Proinflammatory Conditions (2016) (2)
Regulation of endothelial function in coronary microcirculation by HMG-CoA reductase drugs. (2002) (2)
P739Phosphodiesterase 5A expression is up-regulated in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity by the omega-3 fatty acid docosahexaenoic acid (2014) (2)
44Sociodemographic and cardiovascular status but not anticoagulant choice independently predicts quality of life in patients with atrial fibrillation: results from the prefer in AF registry (2014) (2)
[Effects on vasomotor tone and hemostatic function of radiologic contrast media used during invasive cardiological procedures]. (1999) (2)
Endothelial cell transfections: a way for studying promoter activity of genes involved in atherogenesis. (2000) (2)
2212PCSK9 inhibition decreases endothelial nitric oxide synthase activation in response to inflammatory conditions in endothelial cells (2017) (2)
Spontaneous conversion in patients with non‐valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE‐AF) trial (2019) (2)
Minimally aggressive treatment of spontaneous coronary artery dissections. (2013) (2)
[Ranolazine in the prevention of anthracycline-related cardiotoxicity]. (2013) (2)
Clustering of blood cell count abnormalities and future risk of death (2021) (2)
Reprint of “Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis” ☆ (2014) (2)
3.P.192 Early degrees of LDL oxidation induce VCAM-1 expression in cultured endothelial cells (1997) (2)
High-sensitivity troponin I with or without ultra-sensitive copeptin for the instant rule-out of acute myocardial infarction (2022) (2)
Why include the humanities in medical studies (2020) (2)
[Glycemic control in the coronary care unit: prognostic value and new therapeutic strategies]. (2008) (2)
[Myocardial infarct before 45 years of age: significance of the coronarographic study in asymptomatic patients]. (1987) (2)
Comparing TEE‐ vs Non–TEE‐guided cardioversion of atrial fibrillation: The ENSURE‐AF trial (2020) (2)
ω3 Fatty Acids in Renal Diseases (1994) (2)
Abstract 17513: Edoxaban for the Prevention of Thromboembolism in Patients With Bioprosthetic Valves in ENGAGE AF-TIMI 48 (2016) (2)
Questionable levels of evidence in new atrial fibrillation guidelines (2013) (2)
[Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases]. (2003) (2)
Opportunities and challenges in nutrigenetics/nutrigenomics and health. (2010) (2)
[The AVERROES study]. (2011) (2)
Effects of systemic glucocorticosteroids on peripheral neutrophil functions in asthmatic subjects: an ex vivo study (1995) (2)
Response to “Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance” (2008) (2)
Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials (2020) (2)
Inhibiting thrombosis without causing bleeding: can EP3 blockers fulfil the dream? (2014) (2)
Coronary computed tomography angiography, ECG stress test and nuclear imaging as sources of false-positive results in the detection of coronary artery disease (2018) (2)
Morbidity and mortality related to orthostatic hypotension: results of a meta-analysis of non-randomized observational studies (2013) (2)
Vascular dysfunction in HIV‐infected patients (2012) (1)
The nomenclature vagaries for the clinical manifestations of myocardial ischemic syndromes - A call to action. (2019) (1)
The C 242 T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk Two case-control studies and a meta-analysis (2017) (1)
Psychology of Decision-Making and Consumer Protection: the Problem of «Misleading Commercial Practices» (2010) (1)
[Aspirin for primary cardiovascular disease prevention - an update]. (2017) (1)
Vascular prostacyclin in coronary artery disease patients after dietary supplementation with n-3 polyunsaturated fatty acids (1990) (1)
Perspectives in noninvasive imaging for chronic coronary syndromes. (2022) (1)
P699High glucose and hyperosmolar stress increase the expression of COX-2 and AQP1 in aorta of type 1 diabetic mice developing atherosclerosis: implication for unstable vascular disease in diabetes (2017) (1)
Extent and progression of atherosclerosis in carotid and subclavian arteries: the Carotid Artery Subclavian Artery study (2021) (1)
Abstract 14643: Apixaban Plus Mono versus Dual Antiplatelet Therapy After Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial (2014) (1)
Summary Statement: Clinical Trials with ω3 Fatty Acids (1994) (1)
The effect of n-3 fatty acids on lipid and lipoprotein metabolism. (1993) (1)
Role of polyunsaturated fatty acids in experimental models of renal disease. (1993) (1)
[Antithrombotic therapy for unstable angina in non-q myocardial infarct]. (1998) (1)
P617Peroxisome proliferator activated receptor(PPAR)alpha\gamma agonist aleglitazar reduces the inflammatory-mediated expression of monocyte chemoattractant protein(MCP)-1 selectively in human adipocytes (2014) (1)
[Cardiac tumors: role of magnetic resonance imaging]. (2017) (1)
Inflammation and early events in atherogenesis. (1999) (1)
The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project. (2023) (1)
Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry. (2020) (1)
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care (2022) (1)
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases. (2022) (1)
Sociodemographic and cardiovascular status but not anticoagulant choice independently predicts quality of life in patients with atrial fibrillation: Results from the PREFER in AF registry (2014) (1)
[Genetic determinants of response to vitamin K antagonists]. (2014) (1)
Exercise-Induced Pulmonary Hypertension Is Associated with High Cardiovascular Risk in Patients with HIV (2022) (1)
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications (2022) (1)
[Iron and stable ischemic heart disease - lessons from heart failure]. (2019) (1)
Monitoring antiplatelet therapy: where are we now? (2022) (1)
[The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium]. (1998) (1)
Proceedings of the 11th Congress of the International Society of Nutrigenetics and Nutrigenomics (ISNN 2017) (2018) (1)
Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure : insights from the ARISTOTLE trial (2015) (1)
Scoring atherosclerosis in the search of evidence-based personalized medicine. (2018) (1)
P4900Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation in the PREFER in AF registry (2017) (1)
Glycoprotein IIb-IIIa inhibitors in unstable coronary syndromes and percutaneous interventions--a conservative approach. (2003) (1)
Coffee and Hypertension (2015) (1)
Eighty years of oral anticoagulation: Learning from history. (2021) (1)
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. (1985) (1)
Low rate of worsening renal function after 2 years of treatment with edoxaban in patients from the ETNA-AF-Europe study (2021) (1)
[Relations between FANS, PPI and atrial fibrillation]. (2013) (1)
Detecting the vulnerable carotid plaque: the Carotid Artery Multimodality imaging Prognostic study design. (2022) (1)
Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration? (2022) (1)
[Antiarrhythmia effects of omega-3 fatty acids. A review]. (2002) (1)
Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting (2018) (1)
Deficiency of NDUFC2: Cause or bystander in acute coronary syndromes? (2019) (1)
Hospital admissions for syncope and orthostatic hypotension predict incident cardiovascular disease in older middle-aged patients (2016) (1)
Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry. (2014) (1)
[Antithrombotic therapy in atrial fibrillation: state of the art and perspectives]. (2013) (1)
[Group B vitamins as new variables related to the cardiovascular risk]. (2005) (1)
Interindividual variability in biomarkers of cardiometabolic health after consumption of plant food bioactives and determinants involved. (2017) (1)
[Clinical case of significant "reverse remodeling" after cardiac resynchronization therapy]. (2003) (1)
Anticoagulants in Heart Disease Position Paper Syndromes: ESC Working Group on ThrombosisTask Force on New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary (2012) (1)
Vascular disease and nutrition (2001) (1)
The effect of n-3 polyunsaturated fatty acids on cardiac ventricular arrhythmias - a pilot study. (1993) (1)
Soluble Adhesion Molecules as in vivo Biohumoral Markers of Vascular Cell Activation (2007) (1)
Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden? (2021) (1)
724 Cardiovascular morbidity and mortality related to non-alcoholic fatty liver disease: a systematic review and meta-analysis of prospective studies (2021) (1)
Predictors of strut coverage of drug eluting stent implantation in diabetic patients- Is only on-clopidogrel platelet reactivity enough? Reply. (2019) (1)
Fast versus ultra-slow thrombolytic infusion regimens in patients with obstructive mechanical prosthetic valve thrombosis: a pilot randomized clinical trial. (2021) (1)
COVID-19 cardiological research in France: A nationwide perspective (2021) (1)
Effects of radiologic contrast media on eicosanoid production from cells involved in hemostasis and thrombosis. (1991) (1)
Distal embolization during angioplasty for acute myocardial infarction: is pharmacological protection enough? (2005) (1)
Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test (2022) (1)
Nutrition, food production and health – an agenda also for cardiologists (2015) (1)
Cell-Based Gene Therapies and Stem Cells for Regeneration of Ischemic Tissues (2011) (1)
[Nitrates in cardiology: current role and areas of uncertainty]. (2011) (1)
Association of Circulating Heme Oxygenase-1, Lipid Profile and Coronary Disease Phenotype in Patients with Chronic Coronary Syndrome (2021) (1)
The ARISTOTLE study (2012) (1)
Valvular Heart Disease eoangiogenesis , T-Lymphocyte Infiltration , nd Heat Shock Protein-60 Are Biological allmarks of an Immunomediated Inflammatory rocess in End-Stage Calcified Aortic Valve Stenosis (2016) (1)
Platelet-vessel Wall Interactions with Third-generation Oral Contraceptives: No Evidence of Detrimental Effects (1999) (1)
Comparison of Dabigatran Plus a P2Y12 Inhibitor with Warfarin-Based Triple Therapy across Body Mass Index in RE-DUAL PCI. (2020) (1)
The new ACCF/AHA guidelines on the treatment of dyslipidemia: pros (2014) (1)
Abstract 14839: Transesophageal Echocardiography-Guided Strategy vs Conventional Anticoagulation for Cardioversion of Atrial Fibrillation: An Analysis of Thromboembolic and Bleeding Events From the ENSURE-AF Study (2018) (1)
Bleeding risk score: limits and practicability (2021) (1)
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma. (2023) (1)
[Antiplatelet effects of nitrate derivatives]. (1991) (1)
EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION (2012) (1)
P744Regulation of adiponectin expression by selective molecular components of mediterranean diets in human adipocytes (2014) (1)
Beyond Error Psychology's (Not-So-Easy) Lesson for Consumer Law (2016) (1)
Recent trends in n-3 fatty acid research; cardiovascular diseases. (1993) (1)
Relative sensitivity to double thawing of plasma samples for some tests used in thrombosis research. (1988) (1)
Abstract 4171: Olive Oil Phenolic Antioxidants Reduce Metalloproteinase (MMP)-9 Expression and Release in Human Monocytoid Cells: Possible Contribution to Plaque Stability (2006) (1)
Interpreting myocardial infarction analyses in ISCHEMIA: separating facts from fallacy. (2021) (1)
Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside. (2022) (1)
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy. (2023) (1)
Vasostatin-2 associates with coronary collateral vessel formation in diabetic patients and promotes angiogenesis via angiotensin-converting enzyme 2. (2023) (1)
CO-ACTIVATION OF NUCLEAR FACTOR-KB AND MYOCARDIN/SERUM RESPONSE FACTOR IN CANINE CARDIAC MYOBLASTS EXPOSED TO HIGH LEVELS OF INSULIN (2011) (1)
The Nutrigenetics of Cardiovascular Disease (2019) (1)
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry (2022) (1)
Antithrombotic Therapy in ST‐Segment Elevation Myocardial Infarction (2012) (1)
A Comparative Overview of the Fair Wear and Tear Exception: the Duty of Holders of Temporary Interests to Preserve Property (2002) (1)
‘Patient choice’ concept in AF ESC Guidelines: is the clinician giving up? Reply (2013) (1)
Challenges in ischaemic heart disease: not sleeping enough, not brushing your teeth, and skipping breakfast—three ways of increasing your risk of myocardial infarction? (2020) (1)
[Aspirin in primary prevention of cardiovascular diseases: how to balance risks and benefits]. (2012) (1)
Some Comparative Remarks on JA Pye (Oxford) Ltd v. The United Kingdom (2007) (1)
Atherosclerosis and Mediterranean Diet Polyphenols (2014) (1)
Long-term treatment strategies for atherothrombotic disease: do platelets define the course? (2008) (1)
Abstract 704: The Omega-3 Fatty Acid Docosahexaenoate Attenuates Vascular Inflammation Reducing Endothelial Cyclooxygenase-2 Induction through the Inhibition of Both NADP(H) Oxidase and PKC{varepsilon} (2006) (1)
Is there an 'atherosclerotic continuum' from angina with unobstructed coronary arteries to MINOCA? Reply. (2019) (1)
Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome? (2016) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
Abstract 16978: A History of GI Bleeding is Associated With Increased Risk of Subsequent Bleeding, but Not Stroke: Insights From the ARISTOTLE Trial (2016) (0)
Abstract 1397: Homocysteine Induces Endothelial Activation Through Proteasome Dependent Pathway: Protective Role Of Natural Polyphenolic antioxidants (2006) (0)
Excessive Orthostatic Changes in Blood Pressure Are Associated With Incident Heart Failure in Older Men (2021) (0)
Abstract 3700: Impact of Vascular Events on Mortality in AF Patients: Insights from ACTIVE W (2006) (0)
A Double-Blind Randomized Study of the Antiplatelet Effects of Low-Dose ASA and Placebo in Patients After Myocardial Infarction (1983) (0)
Vascular Pharmacology – New Editorial Board (2011) (0)
apid Decline of Collateral Circulation ncreases Susceptibility to Myocardial Ischemia he Trade-Off of Successful Percutaneous ecanalization of Chronic Total Occlusions (2006) (0)
Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice (2021) (0)
Effects of simulated hyperglycemia in vitro on insulin signaling in endothelial cells (2018) (0)
[Prostaglandins and ischemic cardiopathy]. (1980) (0)
The omega-3 fatty acid DHA down regulates the expression of genes associated with breast and colorectal cancers a whole–genome microarray analysis. (2010) (0)
P5153Net clinical benefit of oral anticoagulation in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF registry (2017) (0)
Urinary and circulating markers of endothelial dysfunction in essential hypertensives with atherosclerolic vascular disease (1996) (0)
Mediterranean diet phytochemicals inhibit endothelial activation through interference with redox-sensitive transcription factors (2002) (0)
Bleeding and the Use of Antiplatelet Agents in the Management of Acute Coronary Syndromes and Atrial Fibrillation (2012) (0)
Mechanisms of progression of renal disease and possible sites of action of n-3 fatty acids. (1993) (0)
3 SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED TO VITAMIN K ANTAGONISTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
Induction of angiogenesis and prevention of apoptosis by implantation of adipose tissue-derived mesenchymal stromal cells on VEGF-releasing PLGA microspheres: A combined growth factor therapy cell transplantation approach (2013) (0)
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction. (2023) (0)
Abstract 15574: Adipose Tissue-Derived Mesenchymal Stem Cells with Myocardin-A and Telomerase Co-Expression Possess Augmented Capacity of Proliferation and Promyogenic Activities (2011) (0)
P375Effects of simulated hyperglycemia in vitro on insulin signaling in endothelial cells (2018) (0)
Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire: Prefer in AF Registry (2013) (0)
List of reviewers for 2010 (2011) (0)
[Effects of isosorbide dinitrate on platelet aggregation and production of thromboxane B2]. (1982) (0)
Nitrates as Antiplatelet Agents (1993) (0)
Chapter 11 – Dietary Modulation of the Inflammatory Response (2008) (0)
Reduced saphenous vein prostacyclin production in the absence of endothelial detachment: a marker of functional damage by high potassium cardioplegic solutions to saphenous vein bypass grafts. (1988) (0)
Abstract: P1140 THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE ATTENUATES INSULIN-INDUCED CD36 EXPRESSION IN HUMAN MISCOVASCULAR ENDOTHELIAL CELLS (2009) (0)
The omega-3 fatty acid docosahexaenoate inhibits tissue factor expression in activated human endothelial cells. (2001) (0)
[Diagnostic usefulness and limits of the ergonovine maleate test]. (1981) (0)
Chapter 6 – Statins and Reduction of Stroke: Cholesterol-Lowering versus Pleiotropic Effects (2004) (0)
P591Transplantation of adipose tissue mesenchymal cells conjugated with functionalized PLGA microspheres promotes revascularization and tissue repair in a murine model of acute myocardial infarction (2014) (0)
Tu-S9:2 Omega-3 fatty acids and atherosclerosis: Evidence and mechanisms (2006) (0)
Normal Circulating NO2/NO3 Levels in Essential Hypertensives With Atherosclerotic Vascular Disease. (1997) (0)
Endothelial dysfunctions: common denominators in vascular disease. (2000) (0)
n-3 Fatty acids in combination with lipid lowering drugs. (1993) (0)
Murine mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes angiogenesis by releasing TIMP2 and MMP2 (2020) (0)
PO15-403 ENDOTHELIAL ACTIVITY IS RELATED TO DIET AND COMPONENTS OF THE METABOLIC SYNDROME, BUT NOT TO ADVANCED GLYCATION END-PRODUCTS IN HEALTHY SWEDISH MEN (2007) (0)
16-43: Hospitalization for syncope and orthostatic hypotension predicts incident cardiovascular disease in older middle-aged patients (2016) (0)
Revascularization Strategies in Multivessel Coronary Artery Disease (2018) (0)
Temporal trend of clinical events in patients with atrial fibrillation on edoxaban therapy: results from the non-interventional global ETNA-AF program (2021) (0)
Microarray analysis of human umbilical vein endothelial cells (HUVEC) treated with the omega-3 fatty acid docosahexaenoic acid (DHA) highlights new anti-atherosclerotic and anti angiogenic properties for fish and fish oil. (2010) (0)
Primary hemostasis after nitroglycerin administration: evaluation by bleeding time and analysis of bleeding curves (1990) (0)
ArticleThe vessels-bone axis: iliac artery calcifications (2021) (0)
P2554Transplantation of adipose tissue mesenchymal cells overexpressing telomerase and myocardin promotes revascularization and tissue repair in a murine model of myocardial infarction (2017) (0)
Correction (2008) (0)
Anticoagulation management in atrial fibrillation: inter-country differences in Western Europe: data from the PREFER in AF registry (2013) (0)
[The healed plaque: tale of a story with good ending - with practical implications]. (2021) (0)
Tu-P7:290 Glycosylation in non-diabetic patients with atherosclerosis (2006) (0)
285Hyperosmolarity-enhanced cox-2 expression contributes to high glucose-induced microangiopathy (2014) (0)
Contents Vol. 1, 2008 (2008) (0)
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin — a persisting dilemma (2007) (0)
[One-year follow-up of Italian patients with atrial fibrillation treated with edoxaban in ETNA-AF Europe]. (2020) (0)
A recent controversy about possession in Scots law revives one of the most classical debates in the civil law tradition (2005) (0)
Dual antiplatelet strategies in patients requiring vitamin K antagonists (2008) (0)
Rejuvenated extracellular vescicles from telomerase/myocardin co-expressing mesenchymal cells promote revascularization and tissue repair in murine myocardial infarction (2020) (0)
Clinical effect, biological background, and research priorities on n-3 fatty acids. Executive Summary. (2001) (0)
Patterns of anticoagulant underuse in European AF patients in 2012 - results from PREFER in AF registry (2013) (0)
Images in cardiovascular medicine. A case of free-floating left atrial thrombus in mitral valve stenosis. (2000) (0)
Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry (2021) (0)
Nitrates as thrombocyte function inhibitors (1994) (0)
Digoxina y mortalidad en pacientes con fibrilación auricular (2018) (0)
[Aspirin in primary cardiovascular prevention - a 2022 update]. (2022) (0)
Soluble adhesion molecules as markers of endothelial activation : what is their basic biology and can they help us predict vascular events? (2007) (0)
[Usefulness, timing and modality of ECG stress testing after myocardial revascularization]. (2018) (0)
n-3 Fatty Acids and Platelet-Vessel Wall Interactions (1992) (0)
598 PREVALANCE AND PREDICTORS OF LONG-TERM CARDIAC SYMPTOMS IN PATIENTS WITH TAKOTSUBO SYNDROME (2022) (0)
SAT0253 PROGNOSTIC VALUE OF CARDIAC MAGNETIC RESONANCE IN SYSTEMIC SCLEROSIS (2019) (0)
Erratum to: Transplantation of Mesenchymal Cells Improves Peripheral Limb Ischemia in Diabetic Rats (2014) (0)
16 Impaired glucose tolerance and cardiovascular outcomes after an acute coronary syndrome—the important role of 1-h plasma glucose at the oral glucose tolerance test (2021) (0)
Therapeutic strategies in thrombosis (2013) (0)
Abstract 713: S 18886 Inhibits Thromboxane A2 Receptor-dependent Tissue Factor Expression, Procoagulant Activity And NADP(H) Oxidase Activation In Stimulated Endothelial Cells (2007) (0)
[Biological and cellular mechanisms of restenosis after transluminal coronary angioplasty]. (1991) (0)
Detrimental effects of late artery opening. Authors' reply (2003) (0)
P2885The CHA2DS2VASc score as a predictor of cardiovascular events in patients without atrial fibrillation (2018) (0)
[Unusual case of interventricular septal defect in tertiary syphilis]. (2002) (0)
Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome? (2016) (0)
The combined use of vitamin K antagonists and antiplatelet agents in atrial fibrillation - patterns of use in the European PREFER in AF registry (2013) (0)
Genetic and nutritional interactions in cardiovascular disease. (2011) (0)
The Peroxisome Proliferator Activated Receptor(ppar)gamma Agonist Rosiglitazone (Rsg) Inhibits Cyclooxygenase(cox)-2 Expression by Suppressing Pkcaplha and Creb Activation (2007) (0)
Novel Oral Anticoagulants (NOACs) Roundtable – Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review (2015) (0)
Plasma homocysteine and soluble adhesion molecules as long-term predictors of cardiovascular events in a healthy population: a nested case-control study (2001) (0)
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
Diabetes research in Vascular Pharmacology - an overview of 2011-2012. (2013) (0)
[Proton pump inhibitors and clopidogrel: an association to avoid?]. (2012) (0)
A Therapeutic Pathway in Patients with Chronic Coronary Syndromes: Proposal for Optimization (2022) (0)
Empagliflozin alleviates diabetic cardiomyopathy via inhibiting excessive autophagy and adverse remodeling in type 1 diabetic mice (2022) (0)
A natural-history study of coronary disease. (2011) (0)
Abstract: P646 TOWARDS AN UNDERSTANDING OF DIABETIC VASCULOPATHY: MECHANISMS OF HYPEROSMOLARITY-RELATED HYPERGLYCAEMIC DAMAGE (2009) (0)
Atrial Fibrillation: Current and Forthcoming Antithrombotic Therapies (2012) (0)
[Effect of isosorbide dinitrate on platelet aggregation and production of thromboxane B2]. (1982) (0)
Fish intake and the risk of coronary disease. (1995) (0)
Michele of a Nutritional Component in the Mediterranean Diet Oleic Acid Inhibits Endothelial Activation : A Direct Vascular Antiatherogenic Mechanism (1999) (0)
Complete myocardial revascularization : between myth and reality. Authors' reply (2005) (0)
Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry (2022) (0)
[Management of acute coronary syndromes in the Abruzzi Region in Italy. Abruzzi Inter-societary Consensus Document.] (2017) (0)
Insulin Levels in Cardiac Myoblasts Conveys the Hypertrophy Signal of High Myocardin / Serum Response Factor B and κ Co-Activation of Nuclear Factor-Gene Regulation : (2014) (0)
[Grey zones on dual antiplatelet therapy. Expert opinion]. (2020) (0)
A unique case of right ventricular myxoma concealed within a thrombus in a patient with Crohn's disease: a problem unresolved even with advanced cardiac MRI. (2022) (0)
Myocardial tissue characterization by segmental T2 mapping in thalassaemia major: detecting inflammation beyond iron. (2023) (0)
[Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives]. (2022) (0)
[Pharmacogenetic algorithms for predicting the appropriate dose of vitamin K antagonists: are they still useful?]. (2014) (0)
[An economic assessment of the use of abciximab as a coronary angioplasty preparation in the Italian health-care context]. (1999) (0)
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How. (2023) (0)
[ETNA-AF study: Italian baseline data and comparison with the European population in atrial fibrillation patients treated with edoxaban]. (2020) (0)
346 IMPACT OF EXERCISE-INDUCED PULMONARY HYPERTENSION ON THE RIGHT VENTRICLE AND WORSENING OF CARDIOVASCULAR RISK IN HIV PATIENTS (2022) (0)
The European Heart Journal: fulfilling the mission. (2022) (0)
13 Isolated exercise-induced pulmonary hypertension is associated with clinical worsening and poor immunological control in HIV patients (2021) (0)
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study (2021) (0)
160 The obesity paradox in atrial fibrillation (2021) (0)
[Membrane platelet receptors and cardiovascular risk: from structure to potential clinical implications]. (2001) (0)
Coronary flow reserve: a new target for treating hypertension (2009) (0)
Urine alkalinisation to prevent contrast-induced acute kidney injury: the prospective, randomised, controlled, open-label TEATE trial. (2022) (0)
Why include the humanities in medical studies? (2019) (0)
Hydroxytyrosol, the Major Olive Oil Phenolic Antioxidant, Regulates Expression and Activity of Matrix Metalloproteinase(mmp)-9 in Human Monocytoid Cells - Possible Contribution to Plaque Stability (2007) (0)
2nd Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN) (2008) (0)
[Dabigatran as an alternative to warfarin for the prevention of thromboembolism in atrial fibrillation]. (2012) (0)
[Nitrates as antiplatelet agents]. (1992) (0)
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis. (2022) (0)
[The optimal time window for percutaneous coronary intervention in thrombolysis-treated ST-elevation myocardial infarction]. (2010) (0)
Aspirin and Prognosis in Heart Failure: A Question of Power. (2018) (0)
[Nitrates as thrombocyte function inhibitors]. (1994) (0)
Detecting the vulnerable carotid plaque: the carotid artery multimodality imaging prognostic study design. (2022) (0)
A Testimonial for Cardiovascular Prevention: Dr. Alexander Leaf, 1920-2012 (2013) (0)
Pollution and coronary risk: how much does it matter? (2022) (0)
P741Transcriptome-based identification of new anti-anti-inflammatory and vasodilating properties of the omega-3 polyunsaturated fatty acid docosahexaenoic acid in vascular endothelial cells under proinfla (2014) (0)
Antiplatelet therapy in patients with acute coronary syndromes and thrombocytopaenia: awaiting for evidence (2021) (0)
[Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?]. (1996) (0)
Impact of Exercise-Induced Pulmonary Hypertension on Right Ventricular Function and on Worsening of Cardiovascular Risk in HIV Patients (2022) (0)
Cardiac Richter's syndrome: a rare case of chronic lymphocytic leukaemia transformation. (2023) (0)
Induction of Endothelial-Leukocyte Interaction by Interferon-&ggr; Requires Coactivation of Nuclear Factor-&kgr;B (2001) (0)
The new in anticoagulation: factor XI inhibitors (2023) (0)
12 Sex-related differential susceptibility to ponatinib-induced cardiotoxicity and its relationship to modulation of notch signalling in a muine model (2021) (0)
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program (2023) (0)
A highly-detailed anatomical study of normal pericardial structures as revealed by in-vivo computed tomography and magnetic resonance images and ex-vivo novel 3D reconstructions from Visible Human Server (2021) (0)
[Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update]. (2001) (0)
Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey Study: Design and Rationale. (2022) (0)
[The inflammatory aspects in the initial phases of atherogenesis]. (1995) (0)
[Angina with normal coronary arteries: a common but often neglected association]. (2012) (0)
[Familial history of ischemic cardiopathy is associated with endothelial dysfunction of the coronary area]. (2000) (0)
Diagnostic and therapeutic approach to the ACS patient (2022) (0)
Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside (2022) (0)
MECHANISMS FOR THE IN VIVO ANTIPLATELET EFFECTS OF ORGANIC NITRATES (1987) (0)
Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis (2021) (0)
Towards a tailored use of eluted drugs for percutaneous coronary interventions. (2010) (0)
Subject Index Vol 3, 2010 (2011) (0)
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study (2021) (0)
Reversal agents for current and forthcoming direct oral anticoagulants. (2023) (0)
[Vascular gene therapy--the choice of procedures as a function of strategies]. (1999) (0)
ST-segment/heart rate hysteresis improves the exercise testing accuracy for coronary artery detection in asymptomatic patients with severe aortic stenosis. (2021) (0)
[Biomarkers in primary cardiovascular prevention: rationale, premises, and promises]. (2017) (0)
The non-vitamin K antagonist oral anticoagulants and heparin-induced prolongation of the activated coagulation time. (2022) (0)
[Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease]. (2020) (0)
European Summer School on Nutrigenomics J Nutrigenetic and Nutrigenomics 2014;7:75–93 DOI: 10.1159/000365938 (2014) (0)
[Diagnosis and treatment of blood volume changes in acute heart failure - a brief practical guide]. (2018) (0)
[The ARISTOTLE study]. (2012) (0)
531 Neuroimaging assessment of unilateral asymptomatic carotid artery stenosis: preliminary results of the carotid artery multi-modality imaging prognostic (camp) study (2021) (0)
The prescriptive dimension of tacit knowledge (2015) (0)
Tu-P7:213 Relationships between autoantibodies against modified LDL and advanced glycation end-products in clinically healthy men (2006) (0)
[Hormone replacement therapy and cardiovascular risk]. (1996) (0)
Endothelial Activation and Olive Oil (2010) (0)
University of Birmingham Net clinical benefit of non-vitamin K antagonist vs vitamin K antagonist anticoagulants in elderly patients with atrial fibrillation (2019) (0)
P203Adenylate cyclase signaling is an important post-receptor determinant of response to all P2Y12 receptor antagonists (2017) (0)
RELATIVE SENSITIVITY OF CARDIAC PROSTACYCLIN AND THROMBOXANE TO INHIBITION BY NON-STEROIDAL ANTIINFLAMMATORY DRUGS IN THE RAT HEART (1987) (0)
4110Thromboembolic and bleeding risk of patients with left-sided mechanical heart prostheses: the FCSA-START-Valvole Study (2017) (0)
The non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with high-normal renal function - A systematic review. (2022) (0)
3.P.193 Advanced glycation end-products induce global endothelial activation (1997) (0)
P6365Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study (2017) (0)
A Testimonial for Cardiovascular Prevention: Dr. Alexander Leaf, 1920-2012 (2013) (0)
Troponins in the definition of myocardial infarction after percutaneous coronary interventions (2013) (0)
Effect of the prostacyclin analogue iloprost on endothelial progenitor cell apoptosis and cytokine paracrine release (2009) (0)
Ω-3 Fatty acids in primary and secondary prevention of coronary artery disease. (1993) (0)
n-3 Polyunsaturated fatty acids in ischaemic heart disease - biochemical and clinical effects. (1993) (0)
1106-182 Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells: A link to the pathogenesis of accelerated atherosclerosis in diabetes (2004) (0)
Abstract 15462: Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial (2017) (0)
Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative (2023) (0)
Subject Index Vol. 1, 2008 (2008) (0)
Circulation: Cardiovascular Quality and Outcomes (2021) (0)
P1660Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function (2017) (0)
Contents Vol 3, 2010 (2011) (0)
Fish oil in the prevention of recurrence of stenosis after coronary angioplasty. (1993) (0)
073_16968-G2 Non-Cardiac Syncope and All-Cause Mortality in Adults: A Meta-Analysis of Prospective Studies (2017) (0)
Lipid modifying effects of n-3 fatty acids in patients with hypertriglyceridemia. (1993) (0)
Erratum to “Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome?” (2016) (0)
[Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents]. (1998) (0)
The use of fish oil in human chronic glomerular disease. (1993) (0)
Do we need P 2 Y 12 inhibitor pretreatment in non-ST elevation acute coronary syndrome ? (2019) (0)
[Pharmacological reperfusion in acute myocardial infarct]. (1998) (0)
P2298High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI (2018) (0)
Microarray analysis of human umbilical vein endothelial cells treated with the omega-3 fatty acid docosahexaenoic acid (DHA) highlights new anti-atherosclerotic and anti-angiogenic properties for fish (2011) (0)
Diabetes research in Vascular Pharmacology - an overview of 2011-2012. (2013) (0)
Impairment of Platelet Behaviour by Isosorbide Dinitrate - Rebuttal (1989) (0)
Effect of atorvastatin reloading on endothelial progenitor cells in patients on chronic statin therapy undergoing percutaneous coronary intervention (2013) (0)
Abstract 18243: Transplantation of Mesenchymal Cells Rejuvenated by Delivery of Telomerase and Myocardin Genes Promotes Revascularization and Tissue Repair in Ischemic Hindlimbs of Apolipoprotein-e-null Mice (2012) (0)
Ultra-fast PubMed accessibility of accepted papers — A new feature of Vascular Pharmacology for the authors (2015) (0)
Time Limited Interests in Land: Setting the scene (2012) (0)
Complete myocardial revascularization: Between myth and reality [5] (multiple letters) (2005) (0)
Microarray analysis of human umbilical vein endothelial cells highlights new anti-inflammatory and vasodilating properties of the omega-3 fatty acid docosahexaenoic acid (2013) (0)
Antithrombotic treatment for patients with paroxysmal atrial fibrillation and a low CHA2DS2-VASc score. (2017) (0)
Abstracts of the 2nd European Summer School on Nutrigenomics (2016) (0)
Therapeutic Advances in Thrombosis: De Caterina/Therapeutic Advances in Thrombosis (2012) (0)
Coronary vasodilation by nitrates: any role for prostaglandins? (1985) (0)
Clinical profile and cardiovascular risk factors of patients treated with novel oral anticoagulants in atrial fibrillation - patterns of use in the European PREFER in AF registry (2013) (0)
Omega-3 fatty acids attenuate constitutive and insulin-induced CD 36 expression through a suppression of PPAR α / γ activity in microvascular endothelial cells (2018) (0)
Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Non-vitamin K-Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel (2017) (0)
“Your Paper, Your Way” – A new initiative by Vascular Pharmacology (2013) (0)
Adequacy and Extent of Myocardial Revascularization (2013) (0)
Action plan for healthy agriculture, healthy nutrition, healthy people (2013) (0)
10th Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN). May 22-26, 2016, Tel Aviv, Israel: Abstracts (2016) (0)
Abstract 2632: Stroke Protection Is Largely Related To Cholesterol-lowering In Lipid-lowering Intervention Trials: A Meta-analysis And Meta-regression (2008) (0)
Sex-related differential susceptibility to ponatinib-induced cardiotoxicity and its relationship to modulation of Notch signaling in a murine model (2021) (0)
Perspectives in CardiologyDo we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome?Precisamos do inibidor da P2Y12 como precarga na síndrome coronária aguda sem elevação do segmento ST? (2016) (0)
Cardiovascular Morbidity and Mortality Related to Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. (2023) (0)
Non-coronary atherosclerosis : additional costs according to involvement of vascular beds (2017) (0)
Response to "non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial". (2022) (0)
T02-P-001 Rosuvastatin is cardioprotective,reducing ischemia/reperfusion injury in rat hearts through a modulation of nitric oxide synthase expression (2005) (0)
HIGH INSULIN IMPAIRS PI-3 KINASE/AKT-MEDIATED INSULIN SIGNALING IN HUMAN ENDOTHELIAL CELLS: AN IN VITRO INDUCTION OF INSULIN RESISTANCE? (2007) (0)
Data for: Mid-term outcomes after percutaneous interventions in coronary bifurcations (2018) (0)
P3476Effects of simulated hyperglycemia in vitro on insulin signaling in endothelial cells (2017) (0)
Percutaneous coronary interventions for non-ST elevation acute coronary syndromes - The two faces of inappropriateness. (2018) (0)
B13: Normal circulating NO2/NO3 levels in essential hypertensives with atherosclerotic vascular disease (1997) (0)
Concepts and remedies in the law of possession (2004) (0)
Decline of Collateral Circulation ncreases Susceptibility to Myocardial Ischemia he Trade-Off of Successful Percutaneous ecanalization of Chronic Total Occlusions (2006) (0)
Are n-3 polyunsaturated fatty acids useful in patients with primary hypercholesterolaemia? (1993) (0)
The Use of 18 F-FDG-PET/CT in the Diagnostic Workup of CIED Infections: Another Perspective (2012) (0)
Transplantation of adipose tissue mesenchymal cells overexpressing telomerase and myocardin promotes activation of the cardiomyogenic program and vasculogenesis, and preserves cardiac function in a murine model of myocardial infarction (2015) (0)
Program PRE-MEETING PARALLEL WORKSHOPS Monday , October 6 Workshop Sessions (2008) (0)
The new ACCF/AHA guidelines on the treatment of dyslipidemia: pros. (2015) (0)
Abstract 18885: CTRP1, an Adipokine Causing Endothelial Dysfunction Through Upregulation of Arginase 1, is Associated With the Severity of Coronary Artery Disease in Patients and Promotes Atherogenesis in Mice (2015) (0)
Transcriptional control and RNA species-Vascular 307 MicroRNA-34 a role in vascular calcification (2016) (0)
The systolic blood pressure vs oxygen consumption slope at the cardiopulmonary exercise test predicts carotid atherosclerosis (2012) (0)
Minor polyphenolic components of the Mediterranean diet inhibit endothelial activation (2000) (0)
Pictorial Review of Normal Pericardial Structures •: A Highly-detailed Anatomical Study as Revealed by In-vivo CT and MR Images and Ex-vivo Novel 3D Reconstructions from Visible Human Server (2021) (0)
Caffeine (2022) (0)
Induction of synthesis of lipocortin-I and inhibition of eicosanoid production in inflammatory cells: Evidence for a cell selectivity in glucocorticoid action (1992) (0)
[Nitro derivatives as antiplatelet agents]. (1994) (0)
Some Fuzzy Ideas about Legal Ontologies (2007) (0)
Frontiers in Cardiovascular Biology. Abstracts of the First Congress of the ESC Council on Basic Cardiovascular Science. Berlin, Germany. July 16-19, 2010. (2010) (0)
Erratum to "Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome?" (2016) (0)
Oral session IV: Novel techniques in evolution of right ventricular function * Thursday 9 December 2010, 16:30-18:00 (2010) (0)
New Anticoagulants as an Alternative to Aspirin in Atrial Fibrillation - Implications of the Apixaban versus Acetylsalicylic Acid to Prevent Strokes (AVERROES) Trial (2011) (0)
Marine n-3 Fatty Acids and Vascular Disease a of (2018) (0)
Clinical experience with apixaban in atrial fibrillation: implications of AVERROES (2011) (0)
Chapter 17 Chronic Ischaemic Heart Disease (2009) (0)
Hyperosmolarity-enhanced COX-2 expression contributes to high glucose-induced angiogenesis (2013) (0)
[Aspirin for primary cardiovascular disease prevention - an update]. (2017) (0)
PROSTACYCLIN IMPROVES TRANSCORONARY MYOCARDIAL DELIVERY OF ADIPOSE TISSUE-DERIVED STROMAL CELLS (2007) (0)
Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing (2023) (0)
P742Transcriptome-based identification of new anti-anti-inflammatory properties of the omega-3 fatty acid docosahexaenoic acid in vascular endothelial cells under proinflammatory conditions (2014) (0)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial Short title: NOACs in rheumatic atrial fibrillation (2015) (0)
In-vivo assessment of skeletal muscle ischemia in diabetic rats by MR angiography, MR imaging and proton MR spectroscopy (2012) (0)
Detrimental effects of late artery opening. (2003) (0)
P4604Residual stroke risk of anticoagulated patients with atrial fibrillation: PREFER in AF European registry (2017) (0)
Omega 3 fatty acids in renal diseases. (1994) (0)
The OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC[epsiv]: POSSIBLE INVOLVEMENT OF 15-Lipoxigenase(lo)-1 (2007) (0)
[The use of picotamide in nephropathy with mesangial IgA deposits. The effect on thromboxane generation]. (1993) (0)
Abstract 17617: History of Bleeding and Outcomes with Apixaban versus Warfarin in Patients with Atrial Fibrillation in the ARISTOTLE Trial (2014) (0)
N-3 fatty acids in the treatment of diabetic patients - Biological rationale and clinical data Received for publication 26 June 2006 and accepted in revised form 10 January 2007. Short title: N-3 fatty acids and diabetes (2007) (0)
ST-segment/heart rate hysteresis improves the exercise testing accuracy for coronary artery detection in asymptomatic patients with severe aortic stenosis. (2020) (0)
Homocysteine and Endothelial Dysfunction (2007) (0)
Gastroesophageal Reflux Disease Stimulation of NSAID-Associated Atrial Fibrillation—Reply (2011) (0)
La clausola circa (2018) (0)
[Ten questions awaiting for a definitive answer on the use of non-vitamin K oral anticoagulants in atrial fibrillation]. (2016) (0)
Management of pregnant women with artificial heart valves: inconsistency in ESC publications: reply (2007) (0)
Acknowledgement to Reveiwers (2011) (0)
Abstracts of the 2nd Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN). October 6-8, 2008. Geneva, Switzerland. (2008) (0)
Response to "Current evidence and future perspective for the management of left sided prosthetic valve thrombosis". (2022) (0)
Anticoagulant Therapy in Atrial Fibrillation - Time for a Change? (2009) (0)
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Raffaele De Caterina?

Raffaele De Caterina is affiliated with the following schools:

Raffaele De Caterina's Academic­Influence.com Rankings

Why Is Raffaele De Caterina Influential?

Raffaele De Caterina's Published Works

Published Works

What Schools Are Affiliated With Raffaele De Caterina?

Raffaele De Caterina's AcademicInfluence.com Rankings